Maynard Um
-
-
-
-
-
-
-
FDA selects 7 companies for domestic drug manufacturing pilot
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Lowered to $860 at Wolfe Research
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Lowered to $778 at Truist Securities
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Lowered to $769 at Truist Securities
-
-
-
-
-
-
-
Regeneron wins FDA approval for gene therapy treating rare hearing loss
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Lowered to $921 at Bernstein SocGen
-
-
-
-
-
-
-
Dupixent approved in Japan for bullous pemphigoid treatment
-
439,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

